Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

October 2022

How Labs Can Improve Their Relationships with Payers for Genomic Test Reimbursement

This is an excerpt of a 2,215-word article in the October 10, 2022 issue of  THE DARK REPORT. The full article is available to subscribers. CEO SUMMARY: For payers and health plans, it may be a matter of trust that initially ensures new and novel genomic test reimbursement. A panel of experts at the Executive War College offered insights on effective […]

To access this post, you must purchase The Dark Report.

How Labs Can Improve Their Relationships with Payers for Genomic Test Reimbursement Read More »

Getting the Jump on Solving Major Lab Issues

Observant laboratory managers and pathologists will note a recurring theme among the business intelligence briefings in this issue of The Dark Report: Solutions to major challenges require proactive steps.  A case in point comes with our lead story about how to recruit and retain medical technologists (MTs), medical laboratory scientists (MLSs), and medical laboratory technicians

To access this post, you must purchase The Dark Report.

Getting the Jump on Solving Major Lab Issues Read More »

Insights and Advice about the Lab Staffing Crisis

CEO SUMMARY: For the past decade, it’s been recognized that the supply of skilled laboratory professionals is inadequate to meet the needs of the nation’s clinical laboratories and anatomic pathology groups. Leadership at American Medical Technologists recommends steps that labs can take to encourage more individuals to opt for a career in the lab profession.

To access this post, you must purchase The Dark Report.

Insights and Advice about the Lab Staffing Crisis Read More »

AI Fuels New Efforts in Computational Pathology

CEO SUMMARY: Computational pathology combines technology and data science to improve laboratory medicine. Mayo Clinic is exploring how this new model can improve productivity and diagnostic accuracy in ways that even labs at smaller hospitals can put into practice. Success will stem from interdisciplinary cooperation between pathologists and data scientists. MAYO CLINIC IS CURRENTLY SETTING

To access this post, you must purchase The Dark Report.

AI Fuels New Efforts in Computational Pathology Read More »

How Genomic Testing Labs Can Improve Their Relationships with Payers

CEO SUMMARY: For payers and health plans, it may be a matter of trust that initially curtails speedy reimbursement of new and novel genomic test claims. A panel of experts at the Executive War College offered insights on effective ways that genetic testing laboratories can establish that trust early on with payers. From there, clinical labs must then navigate obstacles while effectively demonstrating the value to patients of genomic tests

To access this post, you must purchase The Dark Report.

How Genomic Testing Labs Can Improve Their Relationships with Payers Read More »

Thermo Fisher Expands Menu to Offset COVID-19 Decreases

IT’S NOT JUST CLINICAL LABORATORIES seeking ways to repurpose the analyzers and automation they used to perform SARS-CoV-2 testing. As the pandemic continues to ease, some in vitro diagnostics (IVD) companies want to help their lab customers by expanding the types of diagnostic tests than can be run on these instrument systems.  This is true

To access this post, you must purchase The Dark Report.

Thermo Fisher Expands Menu to Offset COVID-19 Decreases Read More »

Labs Must Audit Their Cybersecurity Measures

CEO SUMMARY: While clinical laboratory managers and pathologists are aware of the risks of a data breach, they often assume that related protection measures are working as needed. That is a mistake. With the cost of healthcare data breaches on the rise, it is vitally important for labs and hospitals to ensure that their defenses

To access this post, you must purchase The Dark Report.

Labs Must Audit Their Cybersecurity Measures Read More »

October 10, 2022 Intelligence: Late-Breaking Lab News

Future regulation of laboratory-developed tests (LDTs) may not be as clear as it once appeared. On Sept. 30, Congress passed a short-term resolution to keep the federal government funded. As part of the move, a proposed bill to increase oversight of LDTs has been sidelined, at least for now, according to law firm Ropes &

To access this post, you must purchase The Dark Report.

October 10, 2022 Intelligence: Late-Breaking Lab News Read More »

;